A local maker of sterile vials and syringes has named an industry veteran as its next vice president of business development.
Grand Rapids-based Grand River Aseptic Manufacturing, or GRAM, hired David Powell for the role, according to the company this week.
“I am thrilled to welcome Dave to our team as GRAM is ready to embark upon a significant expansion,” said Tom Ross, president and CEO, GRAM.
“Dave has a strong passion for pharmaceutical manufacturing with a focus on quality. His organization leadership and commercial-scale project expertise are invaluable as we continue to grow.”
Powell said he is “honored” to become part of GRAM’s leadership team.
“The quality focus, impressive facility expansion and company culture stand out,” Powell said. “It’s a privilege to be part of this team. I look forward to educating the biopharmaceutical industry on the quality processes, capabilities and customer service found at GRAM.”
During his nearly 30-year career, Powell has led personnel in Europe, India, Japan and Australia and has extensive experience in portfolio management, quality assurance, problem solving and operations.
Prior to joining GRAM, Powell held leadership roles at Abbott, Hospira and most recently, Pfizer, where he was senior director of development services and commercial accounts for the global CentreOne contract development and manufacturing business.
Founded in 2010, GRAM provides sterile parenteral development, manufacturing, testing and regulatory filing support for the life sciences and pharmaceutical industries.
The company expects to open a 60,000-square-foot facility in 2020, which will be its fifth location in Grand Rapids.
The expansion is expected to grow its workforce from 150 to 250 employees.
GRAM reported 2018 revenue of $27.4 million.